4 11 1001 Italian
12 20 1002 chemical
21 26 1003 giant
27 37 1004 Montedison
38 42 1005 S.p.
43 46 1006 A.,
47 54 1007 through
55 58 1008 its
59 69 1009 Montedison
70 81 1010 Acquisition
82 86 1011 N.V.
87 95 1012 indirect
96 100 1013 unit
100 101 1014 ,
102 107 1015 began
108 111 1016 its
112 113 1017 $
113 123 1018 37-a-share
124 130 1019 tender
131 136 1020 offer
137 140 1021 for
141 144 1022 all
145 148 1023 the
149 155 1024 common
156 162 1025 shares
163 174 1026 outstanding
175 177 1027 of
178 186 1028 Erbamont
187 192 1029 N.V.,
193 194 1030 a
195 200 1031 maker
201 203 1032 of
204 219 1033 pharmaceuticals
220 232 1034 incorporated
233 235 1035 in
236 239 1036 the
240 251 1037 Netherlands
251 252 1038 .
256 259 2001 The
260 265 2002 offer
265 266 2003 ,
267 277 2004 advertised
278 280 2005 in
281 286 2006 today
286 288 2007 's
289 297 2008 editions
298 300 2009 of
301 304 2010 The
305 309 2011 Wall
310 316 2012 Street
317 324 2013 Journal
324 325 2014 ,
326 328 2015 is
329 338 2016 scheduled
339 341 2017 to
342 348 2018 expire
349 351 2019 at
352 355 2020 the
356 359 2021 end
360 362 2022 of
363 371 2023 November
371 372 2024 .
376 386 3001 Montedison
387 396 3002 currently
397 401 3003 owns
402 407 3004 about
408 410 3005 72
410 411 3006 %
412 414 3007 of
415 423 3008 Erbamont
423 425 3009 's
426 432 3010 common
433 439 3011 shares
440 451 3012 outstanding
451 452 3013 .
456 459 4001 The
460 465 4002 offer
466 468 4003 is
469 474 4004 being
475 483 4005 launched
484 492 4006 pursuant
493 495 4007 to
496 497 4008 a
498 508 4009 previously
509 518 4010 announced
519 528 4011 agreement
529 536 4012 between
537 540 4013 the
541 550 4014 companies
550 551 4015 .
